No matter how incredible they look and perform, no matter the powertrains fitted under their hoods, or the creature comforts lurking inside, customized half-tons will never be capable of driving their ...
BANNOCKBURN, Ill. and CAMBRIDGE, Mass., Oct. 05, 2015 (GLOBE NEWSWIRE) -- Baxalta Incorporated (NYSE:BXLT) and Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), today announced the initiation of a pivotal ...
Baxalta Incorporated, a biotechnology company, and Momenta Pharmaceuticals, Inc., a biotechnology company, announced the initiation of a pivotal clinical trial in patients with chronic plaque ...
BANNOCKBURN, Ill. and CAMBRIDGE, Mass., Dec. 21, 2015 (GLOBE NEWSWIRE) -- Baxalta Incorporated (NYSE:BXLT) and Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), today announced that M923 met the primary ...
psoriasis Momenta has announced their adalimumab biosimilar candidate, M923, has met its Phase 3 primary endpoint of at least 75% reduction in the Psoriasis Area and Severity Index (PASI-75) following ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results